FDA Insurance Labelling 
STAT
MARCH 8, 2024
regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment. Novo said it has also filed for a label expansion in Europe and a decision is expected this year.
The Checkup by Singlecare
JUNE 28, 2024
It’s in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, approved by the Food and Drug Administration (FDA) to manage blood sugar levels in adults with Type 2 diabetes when combined with diet and exercise. In fact, the drug often sees shortages due to high demand for off-label prescriptions for weight loss.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
AUGUST 20, 2024
And a group of researchers — including two from the FDA’s Center for Drug Evaluation and Research — think artificial intelligence could uncover more signs of these issues, including from electronic health records, social media posts, and clinical databases referencing certain drugs.
The Checkup by Singlecare
AUGUST 31, 2023
Is Mounjaro covered by insurance? | How much does Mounjaro cost without insurance? | How to get Mounjaro without insurance Mounjaro (tirzepatide) is a brand-name prescription drug FDA-approved to control blood sugar levels in people with Type 2 diabetes. Only some insurance providers will cover it. mL of 5 mg/0.5
pharmaphorum
SEPTEMBER 10, 2021
Some insurers have refused to cover the drug, citing what they claim is unproven efficacy for the anti-amyloid drug, as well as the risk of adverse events, while the FDA has also come under fire over its handling of the review and approval. Shares in Biogen closed down a little under 7% yesterday after the presentation.
The Checkup by Singlecare
NOVEMBER 9, 2023
Food and Drug Administration (FDA) just approved Zepbound (tirzepatide) for chronic weight management. The injectable medication is a new version of Eli Lilly’s Mounjaro, which is approved by the FDA to control blood sugar in people with Type 2 diabetes. Zepbound, on the other hand, has been FDA-approved for weight loss.
The Checkup by Singlecare
DECEMBER 28, 2023
Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.
Expert insights. Personalized for you.
143 
Let's personalize your content